Pacer Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Pacer Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,675	Closed	-$122K	–	1195
2017 Q4	$122K	Sell	2,675 -9,941	-79%	-$496K	0.01%	946
2017 Q3	$566K	Buy	+12,616	New	+$430K	0.05%	604
2017 Q1	–	Sell	-7,927	Closed	-$149K	–	1091
2016 Q4	$149K	Buy	7,927 +6,450	+437%	+$158K	0.02%	961
2016 Q3	$44K	Buy	1,477 +120	+9%	+$3.73K	0.01%	1012
2016 Q2	$52K	Buy	+1,357	New	+$56.3K	0.01%	1031

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Pacer Advisors's JUNO Position: Q1 2018 in Review

Pacer Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,675 shares — an estimated $122K sold.

Pacer Advisors first reported a position in JUNO in Q2 2016 and held it in 5 quarters. The position peaked at $566K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Pacer Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Pacer Advisors sold 2,675 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $122K.
Pacer Advisors first reported a position in Juno Therapeutics, Inc. in Q2 2016 and held it in 5 quarters.
Pacer Advisors's Juno Therapeutics, Inc. position peaked at $566K in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Pacer Advisors's 13F filing for Q1 2018, filed 14 May 2018.